COSMOS Pharmaceutical Corporation (TYO:3349)
Japan
· Delayed Price · Currency is JPY 7,261.00
-158.00 (-2.13%)
Jan 31, 2025, 3:30 PM JST
COSMOS Pharmaceutical Cash Flow Statement
Financials in millions JPY. Fiscal year is June - May.
Millions JPY. Fiscal year is Jun - May.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Nov '24 Nov 30, 2024 | May '24 May 31, 2024 | May '23 May 31, 2023 | May '22 May 31, 2022 | May '21 May 31, 2021 | May '20 May 31, 2020 | 2019 - 2015 |
| Net Income | 37,949 | 33,719 | 32,773 | 33,048 | 38,596 | 30,402 | Upgrade
|
| Depreciation & Amortization | 21,102 | 19,924 | 17,368 | 15,110 | 13,785 | 13,562 | Upgrade
|
| Loss (Gain) From Sale of Assets | 1,164 | 937 | 113 | -195 | -4,159 | 47 | Upgrade
|
| Other Operating Activities | -8,968 | -8,646 | -9,034 | -13,188 | -9,090 | -8,393 | Upgrade
|
| Change in Accounts Receivable | -163 | -185 | -254 | -97 | 8 | 289 | Upgrade
|
| Change in Inventory | -8,577 | -8,704 | -11,156 | -5,853 | -7,006 | -295 | Upgrade
|
| Change in Accounts Payable | 6,889 | 17,697 | 22,627 | 6,183 | -3,491 | 25,736 | Upgrade
|
| Change in Other Net Operating Assets | 3,918 | 433 | 1,997 | -2,814 | -768 | 4,113 | Upgrade
|
| Operating Cash Flow | 53,314 | 55,175 | 54,434 | 32,194 | 27,875 | 65,461 | Upgrade
|
| Operating Cash Flow Growth | -2.24% | 1.36% | 69.08% | 15.49% | -57.42% | 90.41% | Upgrade
|
| Capital Expenditures | -49,779 | -55,810 | -46,636 | -43,497 | -26,064 | -25,948 | Upgrade
|
| Sale of Property, Plant & Equipment | 715 | 718 | 46 | 1,519 | 8,677 | - | Upgrade
|
| Other Investing Activities | -2,231 | -2,237 | -2,523 | -1,739 | -1,994 | -1,008 | Upgrade
|
| Investing Cash Flow | -51,295 | -57,329 | -49,113 | -43,717 | -19,381 | -26,956 | Upgrade
|
| Long-Term Debt Issued | - | 18,400 | 10,000 | 300 | - | - | Upgrade
|
| Long-Term Debt Repaid | - | -3,193 | -1,628 | -1,486 | -1,486 | -1,486 | Upgrade
|
| Net Debt Issued (Repaid) | 14,287 | 15,207 | 8,372 | -1,186 | -1,486 | -1,486 | Upgrade
|
| Repurchase of Common Stock | -1 | - | - | -2 | - | - | Upgrade
|
| Dividends Paid | -4,760 | -4,659 | -3,266 | -3,266 | -2,277 | -2,077 | Upgrade
|
| Other Financing Activities | -2,113 | -2,021 | -1,861 | -1,768 | -1,744 | -1,842 | Upgrade
|
| Financing Cash Flow | 7,413 | 8,527 | 3,245 | -6,222 | -5,507 | -5,405 | Upgrade
|
| Miscellaneous Cash Flow Adjustments | 1 | - | - | - | -2 | - | Upgrade
|
| Net Cash Flow | 9,433 | 6,373 | 8,566 | -17,745 | 2,985 | 33,100 | Upgrade
|
| Free Cash Flow | 3,535 | -635 | 7,798 | -11,303 | 1,811 | 39,513 | Upgrade
|
| Free Cash Flow Growth | 419.09% | - | - | - | -95.42% | 640.08% | Upgrade
|
| Free Cash Flow Margin | 0.36% | -0.07% | 0.94% | -1.50% | 0.25% | 5.77% | Upgrade
|
| Free Cash Flow Per Share | 44.60 | -8.01 | 98.46 | -142.72 | 22.87 | 498.91 | Upgrade
|
| Cash Interest Paid | 163 | 101 | 51 | 52 | 60 | 68 | Upgrade
|
| Cash Income Tax Paid | 9,481 | 8,993 | 9,111 | 13,337 | 9,103 | 8,369 | Upgrade
|
| Levered Free Cash Flow | -1,847 | -7,985 | 5,044 | -15,323 | -2,005 | 33,955 | Upgrade
|
| Unlevered Free Cash Flow | -1,746 | -7,923 | 5,076 | -15,291 | -1,967 | 33,998 | Upgrade
|
| Change in Net Working Capital | -4,426 | -8,274 | -15,513 | 5,527 | 10,405 | -28,200 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.